Compare ODC & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ODC | BLFS |
|---|---|---|
| Founded | 1941 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 1994 | 2013 |
| Metric | ODC | BLFS |
|---|---|---|
| Price | $100.25 | $28.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 119.8K | ★ 1.0M |
| Earning Date | 06-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.13% | N/A |
| EPS Growth | 50.45 | ★ 77.27 |
| EPS | ★ 1.69 | 0.02 |
| Revenue | ★ $485,572,000.00 | $96,214,000.00 |
| Revenue This Year | N/A | $19.73 |
| Revenue Next Year | N/A | $17.82 |
| P/E Ratio | ★ $59.37 | $1,405.50 |
| Revenue Growth | 10.97 | ★ 16.97 |
| 52 Week Low | $45.61 | $17.86 |
| 52 Week High | $106.84 | $30.00 |
| Indicator | ODC | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 70.98 | 61.64 |
| Support Level | $70.50 | $23.80 |
| Resistance Level | N/A | $28.90 |
| Average True Range (ATR) | 3.37 | 1.43 |
| MACD | 0.07 | 0.09 |
| Stochastic Oscillator | 56.43 | 63.90 |
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.